Riskpilot← Back to searchSign inGet full accessTerapiaNummi Oy
OYActiveY-tunnus 2975891-5Eerikinkatu 22-A16Other human health activities n.e.c. · NACE 8699Est. 201912 employeeswww.terapianummi.fi
Revenue 2025
EUR 911K
+6% vs 2024
EBITDA margin
14.3%
+36% vs 2024
Equity ratio
58.7%
Financial strength
Net profit 2025
EUR 104K
+36% vs 2024
| Revenue | EUR 911K | +6% |
| EBITDA | EUR 131K | +36% |
| Net profit | EUR 104K | +36% |
| Total assets | EUR 285K | +18% |
| Equity | EUR 167K | +17% |
| Employees | 12 | — |
Legal name
TerapiaNummi Oy
Y-tunnus number
2975891-5
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
4. helmikuuta 2019
Share capital
EUR 2 500
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Toimintaterapia, ohjaus ja valmennus, terveys-, hyvinvointi- ja kuntoutuspalvelut sekä kaikki laillinen liiketoiminta.
Address
Eerikinkatu 22-A16
Email
toimisto@terapianummi.fi
Website
www.terapianummi.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 625 | 597 | 862 | 863 | 911 |
| Staff expenses | −124 | −188 | −423 | −516 | −559 |
| EBITDA | 134 | 87 | 118 | 96 | 131 |
| Depreciation & amort. | −1 | — | −0 | −0 | −0 |
| EBIT | 133 | 87 | 118 | 96 | 131 |
| Net financials | −0 | −0 | −0 | 0 | 0 |
| Profit before tax | 133 | 87 | 118 | 96 | 131 |
| Tax | 27 | 17 | 24 | 19 | 26 |
| Net profit | 106 | 69 | 94 | 77 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 195 | 208 | 216 | 241 | 285 |
| Equity | 153 | 122 | 126 | 143 | 167 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 42 | 86 | 90 | 98 | 118 |
| Total debt | 42 | 86 | 90 | 98 | 118 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
58.7%
This company
38.2%
Market median
+54% vs market
20212025
Return on equity
62.3%
This company
18.4%
Market median
+239% vs market
20212025
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20212025
Asset turnover
3.20×
This company
1.12×
Market median
+186% vs market
20212025
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MM Chief Executive Officer | Chief Executive Officer | 2019 |
MK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2019 |
TR | Audit | 2019 |
| Former (1) | ||
OA Deputy auditor | Deputy auditor | 2019 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TerapiaNummi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Osmo Antero Soinio | Deputy auditor | 0 companies |
| Mia-Riikka Marjatta Nummi | Chief Executive Officer | 0 companies |
| Marjut Katariina Nummi | Deputy Chief Executive Officer | 0 companies |
| Tuukka Raimo Johannes Ruoho | Audit | 0 companies |